Interferon-gamma treatment of human umbilical cord mesenchymal stem cells can significantly reduce damage associated with diabetic peripheral neuropathy in mice
CONCLUSION: Interferon-gamma treatment of umbilical cord mesenchymal stem cells enhanced osteogenic differentiation, adipogenic differentiation, and proliferative potential. It can enhance the ability of human umbilical cord mesenchymal stem cells to alleviate damage to diabetic nerve fibers and Schwann cells, in addition to improving the neurological function of diabetic mice.PMID:37644749 | DOI:10.2174/1574888X19666230829155046
Source: Current Stem Cell Research and Therapy - Category: Stem Cells Authors: Li-Fen Yang Jun-Dong He Wei-Qi Jiang Xiao-Dan Wang Xiao-Chun Yang Zhi Liang Yi-Kun Zhou Source Type: research
More News: Brain | Diabetes | Endocrinology | Lymphoma | Neurology | Pain | Peripheral Neuropathy | Stem Cell Therapy | Stem Cells | Study